Correction

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker

Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa M. Nafady
African Journal of Laboratory Medicine | Vol 11, No 1 | a1713 | DOI: https://doi.org/10.4102/ajlm.v11i1.1713 | © 2022 Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa Nafady | This work is licensed under CC Attribution 4.0
Submitted: 27 August 2021 | Published: 25 March 2022

About the author(s)

Asmaa M. Zahran, Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt
Hanaa Nafady-Hego, Department of Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt
Sawsan M. Moeen, Department of Internal Medicine, Clinical Haematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt
Hanan A. Eltyb, Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt
Mohammed M. Wahman, Department of Clinical Oncology, South Valley University, Qena, Egypt
Asmaa M. Nafady, Department of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt


Share this article

Bookmark and Share

Abstract

No abstract available.

Keywords

multiple myeloma; classical monocytes; intermediate monocytes; non-classical monocytes; flow cytometry

Metrics

Total abstract views: 403
Total article views: 172


Crossref Citations

No related citations found.